Literature DB >> 6202022

Inhibition of the human tissue plasminogen activator in plasma from different species.

L Häggroth, C Mattsson, J Friberg.   

Abstract

The rate and extent of complex formation between protease inhibitors present in plasma from different species and a human plasminogen activator purified to homogeneity from the supernatant of a human melanoma cell line was studied in vitro. The fibrinolytic activity of the one-chain plasminogen activator disappeared form human, cat and rabbit plasma with a half-life of 100 minutes. By means of antibodies directed against purified protease inhibitors the main inhibitor in human, cat, dog and rabbit plasma was identified as alpha 2-antiplasmin. Alpha 2-macroglobulin and C1-esterase-inhibitor functioned as inhibitors to a lesser extent. The main inhibitor in rat plasma was alpha 2-macroglobulin. The plasma half-life was 3 (rabbit and human) to 10 (dog and rat) times shorter for the two-chain form than for the one-chain form of the plasminogen activator molecule. It is also concluded that, with respect to plasma elimination of the fibrinolytic activity, among the common laboratory animals, the rabbit is the most suitable animal available for the study of fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202022     DOI: 10.1016/0049-3848(84)90113-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

1.  In vivo distribution of Tc-99m labeled recombinant tissue-type plasminogen activator in control and thrombus-bearing rats.

Authors:  E Tsukamoto
Journal:  Ann Nucl Med       Date:  1992-08       Impact factor: 2.668

2.  The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related.

Authors:  L A Erickson; C M Hekman; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.